Calumet Specialty Products
CLMT
72 hedge funds and large institutions have $31.6M invested in Calumet Specialty Products in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
42% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 19
6% more funds holding
Funds holding: 68 → 72 (+4)
5% more capital invested
Capital invested by funds: $30.1M → $31.6M (+$1.45M)
0.62% less ownership
Funds ownership: 10.34% → 9.72% (-0.62%)
65% less call options, than puts
Call options by funds: $708K | Put options by funds: $2.05M
Top Buyers
Top Sellers
CLMT Hedge Fund Activity: Q2 2017 in Review
72 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q2 2017, worth a combined $31.6M — up 4.8% from $30.1M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CLMT positions and 6 closed out — a net gain of 4 holders — while 27 added to existing stakes and 19 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $571K. The largest seller was Citigroup, cutting an estimated $2.66M.
- 72 institutional investors held Calumet Specialty Products (CLMT) as of Q2 2017, up from 68 in Q1 2017.
- Funds reported $31.6M of Calumet Specialty Products stock for Q2 2017, up 4.8% quarter-over-quarter.
- 10 funds opened new Calumet Specialty Products positions in Q2 2017 and 6 closed out, a net change of +4 holders.
- The largest Calumet Specialty Products buyer in Q2 2017 was Morgan Stanley, an estimated $571K added.
- The largest Calumet Specialty Products seller in Q2 2017 was Citigroup, an estimated $2.66M sold.
Based on aggregated 13F filings for Q2 2017.